BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

523144

MEDICAPQ

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MEDI-CAPS LTD. Share Price Update

As of the latest trading session, MEDI-CAPS LTD. share price is currently at ₹ 42.22, which is up by ₹ 0.26 from its previous closing. Today, the stock has fluctuated between ₹ 41.52 and ₹ 45.69. Over the past year, MEDI-CAPS LTD. has achieved a return of -18.60 %. In the last month alone, the return has been -2.19 %. Read More...

MEDI-CAPS LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    52.64

  • P/E Ratio (TTM)

    104.90

  • Beta

    0.56

  • Book Value / share

    54.16

  • Return on equity

    6.10%

  • EPS (TTM)

    0.40

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -0.26

info icon alternate text

MEDI-CAPS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 0.25
Operating Expense 0.61
Net Profit -0.26
Net Profit Margin (%) -104.00
Earnings Per Share (EPS) -0.21
EBITDA -0.22
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.96
Operating Expense 0.63
Net Profit 0.45
Net Profit Margin (%) 46.87
Earnings Per Share (EPS) 0.36
EBITDA 0.49
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.28
Operating Expense 0.73
Net Profit -0.33
Net Profit Margin (%) -117.85
Earnings Per Share (EPS) -0.27
EBITDA -0.29
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 1.84
Operating Expense 0.96
Net Profit 0.65
Net Profit Margin (%) 35.32
Earnings Per Share (EPS) 0.52
EBITDA 1.18
Effective Tax Rate (%) 42.98
Particulars DEC 2023 (Values in Cr)
Revenue 2.98
Operating Expense 0.91
Net Profit 1.69
Net Profit Margin (%) 56.71
Earnings Per Share (EPS) 1.35
EBITDA 2.18
Effective Tax Rate (%) 21.02
Particulars MAR 2024 (Values in Cr)
Revenue 6.93
Operating Expense 2.49
Net Profit 3.89
Net Profit Margin (%) 56.13
Earnings Per Share (EPS) 3.12
EBITDA 4.99
Effective Tax Rate (%) 19.46
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.49
Net Profit 0.15
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.12
EBITDA 0.35
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.67
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA 0.03
Effective Tax Rate (%) -16.66
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit -0.11
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.90
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 10.91
Operating Expense 20.35
Net Profit -8.33
Net Profit Margin (%) -76.35
Earnings Per Share (EPS) -6.14
EBITDA -7.95
Effective Tax Rate (%) -0.12
Particulars MAR 2024 (Values in Cr)
Book Value / Share 97.02
ROE % -2.03
ROCE % -1.16
Total Debt to Total Equity 0.00
EBITDA Margin 1.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 95.09
ROE % 1.05
ROCE % 3.68
Total Debt to Total Equity 0.00
EBITDA Margin 12.31
Particulars MAR 2022 (Values in Cr)
Book Value / Share 93.23
ROE % 9.12
ROCE % 9.20
Total Debt to Total Equity 0.00
EBITDA Margin 17.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 83.97
ROE % 11.38
ROCE % 11.42
Total Debt to Total Equity 0.00
EBITDA Margin 21.70
Particulars MAR 2020 (Values in Cr)
Book Value / Share 72.94
ROE % -6.27
ROCE % -6.07
Total Debt to Total Equity 0.00
EBITDA Margin -8.63
Particulars MAR 2024 (Values in Cr)
Book Value / Share 53.32
ROE % 6.10
ROCE % 7.57
Total Debt to Total Equity 0.00
EBITDA Margin 69.60
Particulars MAR 2023 (Values in Cr)
Book Value / Share 49.00
ROE % -0.80
ROCE % -0.62
Total Debt to Total Equity 0.00
EBITDA Margin -290.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 49.15
ROE % -0.82
ROCE % -0.87
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 48.89
ROE % 0.02
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share 47.99
ROE % -13.08
ROCE % -12.88
Total Debt to Total Equity 0.00
EBITDA Margin -61.58
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.32
Total Assets 127.28
Total Liabilities 127.28
Total Equity 120.98
Share Outstanding 12469956
Price to Book Ratio 0.83
Return on Assets (%) -1.76
Return on Capital (%) -1.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.11
Total Assets 125.98
Total Liabilities 125.98
Total Equity 118.57
Share Outstanding 12469956
Price to Book Ratio 0.71
Return on Assets (%) 1.39
Return on Capital (%) 1.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 9.75
Total Assets 130.35
Total Liabilities 130.35
Total Equity 116.25
Share Outstanding 12469956
Price to Book Ratio 1.01
Return on Assets (%) 7.73
Return on Capital (%) 8.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.80
Total Assets 114.81
Total Liabilities 114.81
Total Equity 104.71
Share Outstanding 12469956
Price to Book Ratio 0.83
Return on Assets (%) 9.69
Return on Capital (%) 10.63
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.25
Total Assets 95.21
Total Liabilities 95.21
Total Equity 90.95
Share Outstanding 12469956
Price to Book Ratio 0.17
Return on Assets (%) -6.14
Return on Capital (%) -6.43
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 68.09
Total Liabilities 68.09
Total Equity 66.48
Share Outstanding 12469956
Price to Book Ratio 0.83
Return on Assets (%) 5.71
Return on Capital (%) 5.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 61.62
Total Liabilities 61.62
Total Equity 61.10
Share Outstanding 12469956
Price to Book Ratio 0.71
Return on Assets (%) 0.23
Return on Capital (%) 0.24
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.78
Total Assets 61.80
Total Liabilities 61.80
Total Equity 61.28
Share Outstanding 12469956
Price to Book Ratio 1.01
Return on Assets (%) -0.06
Return on Capital (%) -0.06
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.72
Total Assets 62.63
Total Liabilities 62.63
Total Equity 60.96
Share Outstanding 12469956
Price to Book Ratio 0.83
Return on Assets (%) -0.17
Return on Capital (%) -0.18
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.74
Total Assets 61.55
Total Liabilities 61.55
Total Equity 59.84
Share Outstanding 12469956
Price to Book Ratio 0.17
Return on Assets (%) -13.52
Return on Capital (%) -13.9
Particulars MAR 2024 (Values in Cr)
Net Income -1.24
Cash from Operations 7.94
Cash from Investing -7.73
Cash from Financing 0.00
Net change in Cash -0.79
Free Cash Flow 8.29
Particulars MAR 2023 (Values in Cr)
Net Income 4.92
Cash from Operations -3.02
Cash from Investing -2.56
Cash from Financing 0.00
Net change in Cash -8.64
Free Cash Flow -1.86
Particulars MAR 2022 (Values in Cr)
Net Income 10.05
Cash from Operations 7.02
Cash from Investing -4.07
Cash from Financing 0.00
Net change in Cash 2.94
Free Cash Flow 9.81
Particulars MAR 2021 (Values in Cr)
Net Income 11.23
Cash from Operations 15.31
Cash from Investing -9.69
Cash from Financing -0.06
Net change in Cash 5.55
Free Cash Flow 17.57
Particulars MAR 2020 (Values in Cr)
Net Income -5.84
Cash from Operations 4.63
Cash from Investing -5.80
Cash from Financing -0.05
Net change in Cash -1.22
Free Cash Flow 5.88
Particulars MAR 2024 (Values in Cr)
Net Income 4.82
Cash from Operations 4.04
Cash from Investing -3.08
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 4.04
Particulars MAR 2023 (Values in Cr)
Net Income 0.25
Cash from Operations -2.59
Cash from Investing 1.85
Cash from Financing 0.00
Net change in Cash -0.74
Free Cash Flow -2.59
Particulars MAR 2022 (Values in Cr)
Net Income -0.06
Cash from Operations -0.95
Cash from Investing 1.00
Cash from Financing 0.00
Net change in Cash 0.05
Free Cash Flow -0.95
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations 2.23
Cash from Investing -2.18
Cash from Financing -0.06
Net change in Cash -0.01
Free Cash Flow 2.23
Particulars MAR 2020 (Values in Cr)
Net Income -8.31
Cash from Operations -0.92
Cash from Investing -0.40
Cash from Financing -0.05
Net change in Cash -1.38
Free Cash Flow -0.92
Company Name Price P/E P/B Market Cap 52 Week Low/High
ELPRO INTERNATIONAL LTD. 82.25 16.85 0.68 1393.97 62.30 / 147.70
FORBES & COMPANY LTD. 362.25 17.37 2.53 467.30 264.35 / 796.20
GOLDEN TOBACCO LIMITED 40.25 13.37 -0.33 70.88 36.00 / 60.90
PENINSULA LAND LIMITED 28.85 54.43 3.46 934.74 21.05 / 78.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
SANATHNAGAR ENTERPRISES LIMITE 39.96 0.00 -1.00 12.59 25.12 / 87.55
BARODA RAYON CORPORATION LTD. 130.35 19.25 0.86 298.65 120.30 / 215.00
ELPRO INTERNATIONAL LTD. 82.25 22.66 0.72 1393.97 62.30 / 147.70
FORBES & COMPANY LTD. 362.25 16.44 3.25 467.30 264.35 / 796.20

MEDI-CAPS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
42.22 0.61 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 42.80
  • 26 Days 43.90
  • 10 Days 43.20
  • 50 Days 45.10
  • 12 Days 43.30
  • 100 Days 46.80
  • 20 Days 43.70
  • 200 Days 47.90
42.33 PIVOT

First Support

41.38

First Resistance

42.91

Second Support

40.80

Second Resistance

43.86

Third Support

39.85

Third Resistance

44.44

RSI

38.24

ADX

12.07

MACD

-0.65

Williams % R

-84.52

Commodity Channel Index (CCI)

-129.54

Date

2025-04-29

Week

4140.00

Same Day

3949.00

Month

2645.00

1 Year

0.56

3 Year

0.63

Over 1 Month

-2.19%

down

Over 1 Year

-18.60%

down

Over 3 Months

-14.66%

down

Over 3 Years

-8.57%

down

Over 6 Months

-19.32%

down

Over 5 Years

30.72%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

MEDI-CAPS LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
49.2%
Promoter Holdings
50.76%
FII
0.0%
DII
0.02%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Alok K Garg 3225920.0 (25.87%) Shareholding of Promoter and Promoter Group
Manisha Garg 2694820.0 (21.61%) Shareholding of Promoter and Promoter Group
Sangeetha S 694400.0 (5.57%) Public Shareholding
Dheeraj Kumar Lohia 584877.0 (4.69%) Public Shareholding
Trapti Investments Llp 307128.0 (2.46%) Shareholding of Promoter and Promoter Group
Sonal Lohia 178018.0 (1.43%) Public Shareholding
Manju Gaggar 127026.0 (1.02%) Public Shareholding
Akshit Garg 38304.0 (0.31%) Shareholding of Promoter and Promoter Group
Palash Garg 38808.0 (0.31%) Shareholding of Promoter and Promoter Group
Kusum Mittal 12000.0 (0.1%) Shareholding of Promoter and Promoter Group
Ramesh Chandra Mittal 10000.0 (0.08%) Shareholding of Promoter and Promoter Group
Nirmala Mittal 3172.0 (0.03%) Shareholding of Promoter and Promoter Group
Geetika Agrawal 400.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

MEDI-CAPS LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
20 Sep 2012 1.5 Final 24 Sep 2012 Equity shares
22 Sep 2011 1.5 Final 24 Sep 2011 Equity shares
22 Sep 2010 1.5 Final 24 Sep 2010 Equity shares
24 Sep 2009 1.5 Final 28 Sep 2009 Equity shares
24 Sep 2008 1.5 Final 26 Sep 2008 Equity shares
20 Sep 2007 1.5 Final 24 Sep 2007 Equity shares
21 Sep 2006 0.0 Final 25 Sep 2006 Equity shares
22 Sep 2005 0.0 Final 26 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
20 Mar 2013 19 Mar 2013 3:1
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

MEDI-CAPS LTD. Share Price

Medi-caps was incorporated by S L Mittal in Aug.'83 as a private limited company and was converted into a public limited company in Mar.'86. Pharmaceutical companies procure empty hard gelatine capsules from Medi-caps for dosaged medicines meant for oral administration. The company is the second-largest manufacturer of empty hard gelatine capsules in India.

It takes several years for a company manufacturing capsules to attain zero-defect in production and to fully normalise operations. Medi-caps can claim to have achieved this. In Apr.'95, the company offered 6.11 lac rights shares at a premium of Rs 116 to part-finance the Rs 9.19-cr expansion of its manufacturing facilities (from 2000 mln pa to 3440 mln pa) by installing four high-speed automatic capsule-making machines.

The company's manufacturing unit is located in Pithampur, Madhya Pradesh. The company's clientele include US Vitamins, SOL Pharmaceuticals, Dr Reddy's Laboratories, Lupin Laboratories, Aristo Pharmaceuticals, etc. At present, it has 40 clients. The other group company of Medi-caps is Medi-caps Finance which is engaged in finance related activities. In 1993, R C Mittal received the Glory of India International award.

In 1995-96, the company enhanced the capacity of empty hard gelatine capsules by 2500 lac. The company received ISO 9002 Certification during 1998-99. It developed six sizes of the Hard Gelatin Capsules in 2002-03. The company is closely working on commissioning of 13th Machine with 100% automisation. During 2002-03 the company established the export market in countries like China,Thailand,Dubai,Malaysia,South Africa and Philipines.

The Company permanently discontinued its manufacturing activities on 21.11.2019 at the plant in Pithampur, Dhar Dist. and ventured into Real Estate Business and in continuation of this, it executed an agreement with the Tirupati Reality & Developers on 12 October, 2020 for Project named Medicaps Business Park.

Parent organization Indian Private
NSE symbol MEDICAPS
Founded 1983
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Medi Caps Ltd?

Answer Field

The share price of Medi Caps Ltd for NSE is ₹ 11.00 and for BSE is ₹ 42.22.

What is the Market Cap of Medi Caps Ltd?

Answer Field

The market cap of Medi Caps Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 52.60 Cr. as of now.

What is the 52 Week High and Low of Medi Caps Ltd?

Answer Field

The 52 Week High and Low of Medi Caps Ltd for NSE is ₹ 11.00 and ₹ 0.00 and for BSE is ₹ 61.00 and ₹ 41.00.

How to Buy Medi Caps Ltd share?

Answer Field

You can trade in Medi Caps Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Medi Caps Ltd?

Answer Field

The 1 year returns on the stock has been -18.60%.

What is the Current Share Price of Medi Caps Ltd?

Answer Field

Medi Caps Ltd share price is for NSE ₹ 11.00 & for BSE ₹ 42.22 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Medi Caps Ltd Share?

Answer Field

The market cap of Medi Caps Ltd for NSE ₹ 0.0 & for BSE ₹ 52.60 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Medi Caps Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Medi Caps Ltd share is 104.90.

What is the PB ratio of Medi Caps Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Medi Caps Ltd share is 54.16.

How to Buy Medi Caps Ltd Share?

Answer Field

You can trade in Medi Caps Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medi Caps Ltd Share on Bajaj Broking App?

Answer Field

To buy Medi Caps Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medi Caps Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|